
Jennifer Ho's Lab
Clinical and translational patient-oriented investigations to better understand mechanisms driving HFpEF and cardiac remodeling in other obesity-related cardiometabolic diseases.
Forefront of Research
Over half of individuals with heart failure have preserved rather than reduced ejection fraction (HFpEF vs HFrEF), yet therapies remain limited. The Ho Lab conducts clinical and translational patient-oriented investigations to better understand mechanisms driving HFpEF and cardiac remodeling in other obesity-related cardiometabolic diseases.
Learn about our clinical and translational investigations relating to HFpEF